Share on StockTwits

Pacific Biosciences of California (NASDAQ:PACB) released its earnings data on Tuesday. The company reported ($0.26) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.27) by $0.01, Analyst Ratings.Net reports. The company had revenue of $9.10 million for the quarter, compared to the consensus estimate of $9.13 million. During the same quarter last year, the company posted ($0.39) earnings per share. Pacific Biosciences of California’s revenue was up 54.2% compared to the same quarter last year.

Shares of Pacific Biosciences of California (NASDAQ:PACB) traded up 4.35% on Tuesday, hitting $7.20. 924,472 shares of the company’s stock traded hands. Pacific Biosciences of California has a 52 week low of $1.95 and a 52 week high of $8.20. The stock’s 50-day moving average is $5.84 and its 200-day moving average is $4.50. The company’s market cap is $476.3 million.

Pacific Biosciences, Inc develops Deoxyribonucleic Acid (NASDAQ:PACB) sequencing platform.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.